These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 22330921)
1. Artemisinin-naphthoquine combination therapy for uncomplicated pediatric malaria: a tolerability, safety, and preliminary efficacy study. Benjamin J; Moore B; Lee ST; Senn M; Griffin S; Lautu D; Salman S; Siba P; Mueller I; Davis TM Antimicrob Agents Chemother; 2012 May; 56(5):2465-71. PubMed ID: 22330921 [TBL] [Abstract][Full Text] [Related]
2. Artemisinin-naphthoquine combination (ARCO) therapy for uncomplicated falciparum malaria in adults of Papua New Guinea: a preliminary report on safety and efficacy. Hombhanje FW; Linge D; Saweri A; Kuanch C; Jones R; Toraso S; Geita J; Masta A; Kevau I; Hiawalyer G; Sapuri M Malar J; 2009 Aug; 8():196. PubMed ID: 19671190 [TBL] [Abstract][Full Text] [Related]
3. Artemisinin-naphthoquine combination therapy for uncomplicated pediatric malaria: a pharmacokinetic study. Batty KT; Salman S; Moore BR; Benjamin J; Lee ST; Page-Sharp M; Pitus N; Ilett KF; Mueller I; Hombhanje FW; Siba P; Davis TM Antimicrob Agents Chemother; 2012 May; 56(5):2472-84. PubMed ID: 22330923 [TBL] [Abstract][Full Text] [Related]
4. Artemether-lumefantrine versus artemisinin-naphthoquine in Papua New Guinean children with uncomplicated malaria: a six months post-treatment follow-up study. Laman M; Benjamin JM; Moore BR; Salib M; Tawat S; Davis WA; Siba PM; Robinson LJ; Davis TM Malar J; 2015 Mar; 14():121. PubMed ID: 25889150 [TBL] [Abstract][Full Text] [Related]
5. Gametocyte Clearance Kinetics Determined by Quantitative Magnetic Fractionation in Melanesian Children with Uncomplicated Malaria Treated with Artemisinin Combination Therapy. Karl S; Laman M; Moore BR; Benjamin J; Koleala T; Ibam C; Kasian B; Siba PM; Waltmann A; Mueller I; Woodward RC; St Pierre TG; Davis TM Antimicrob Agents Chemother; 2015 Aug; 59(8):4489-96. PubMed ID: 25987625 [TBL] [Abstract][Full Text] [Related]
6. [A randomized clinical trial comparing the effectiveness and tolerability of artemisinine-naphthoquine (Arco®) and artemether-lumefantrine (Coartem®) in the treatment of uncomplicated malaria in Benin]. Kinde-Gazard D; Ogouyèmi-Hounto A; Capo-Chichi L; Gbaguidi J; Massougbodji A Bull Soc Pathol Exot; 2012 Aug; 105(3):208-14. PubMed ID: 22328063 [TBL] [Abstract][Full Text] [Related]
7. Artemisinin-naphthoquine for treating uncomplicated Plasmodium falciparum malaria. Isba R; Zani B; Gathu M; Sinclair D Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD011547. PubMed ID: 25702785 [TBL] [Abstract][Full Text] [Related]
8. A pharmacokinetic approach to assess artemisinin-naphthoquine combination therapy for uncomplicated pediatric malaria. Liu R; Dong HF; Jiang MS Expert Rev Clin Pharmacol; 2012 Sep; 5(5):521-4. PubMed ID: 23121274 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of oral single dose therapy with artemisinin-naphthoquine phosphate in uncomplicated falciparum malaria. Tun T; Tint HS; Lin K; Kyaw TT; Myint MK; Khaing W; Tun ZW Acta Trop; 2009 Sep; 111(3):275-8. PubMed ID: 19464245 [TBL] [Abstract][Full Text] [Related]
10. Open-label trial of three dosage regimens of fixed-dose combination of artemisinin and naphthoquine for treating uncomplicated falciparum malaria in Calabar, Nigeria. Meremikwu MM; Odey F; Oringanje C; Oyo-Ita A; Effa E; Esu EB; Eyam E; Oduwole O; Asiegbu V; Alaribe A; Ezedinachi EN Malar J; 2012 Dec; 11():413. PubMed ID: 23232095 [TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of artemisinin-naphthoquine versus artemether-lumefantrine for the treatment of uncomplicated malaria in Papua New Guinean children. Moore BR; Davis WA; Clarke PM; Robinson LJ; Laman M; Davis TME Malar J; 2017 Oct; 16(1):438. PubMed ID: 29084540 [TBL] [Abstract][Full Text] [Related]
12. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison. Ratcliff A; Siswantoro H; Kenangalem E; Maristela R; Wuwung RM; Laihad F; Ebsworth EP; Anstey NM; Tjitra E; Price RN Lancet; 2007 Mar; 369(9563):757-765. PubMed ID: 17336652 [TBL] [Abstract][Full Text] [Related]
13. Artemisinin-naphthoquine versus artemether-lumefantrine for uncomplicated malaria in Papua New Guinean children: an open-label randomized trial. Laman M; Moore BR; Benjamin JM; Yadi G; Bona C; Warrel J; Kattenberg JH; Koleala T; Manning L; Kasian B; Robinson LJ; Sambale N; Lorry L; Karl S; Davis WA; Rosanas-Urgell A; Mueller I; Siba PM; Betuela I; Davis TM PLoS Med; 2014 Dec; 11(12):e1001773. PubMed ID: 25549086 [TBL] [Abstract][Full Text] [Related]
14. Risk factors for Plasmodium falciparum and Plasmodium vivax gametocyte carriage in Papua New Guinean children with uncomplicated malaria. Karl S; Laman M; Moore BR; Benjamin JM; Salib M; Lorry L; Maripal S; Siba P; Robinson LJ; Mueller I; Davis TM Acta Trop; 2016 Aug; 160():1-8. PubMed ID: 27056132 [TBL] [Abstract][Full Text] [Related]
15. Safety and therapeutic efficacy of artesunate suppositories for treatment of malaria in children in Papua New Guinea. Karunajeewa HA; Kemiki A; Alpers MP; Lorry K; Batty KT; Ilett KF; Davis TM Pediatr Infect Dis J; 2003 Mar; 22(3):251-6. PubMed ID: 12634587 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of artemisinin-naphthoquine versus dihydroartemisinin-piperaquine in adult patients with uncomplicated malaria: a multi-centre study in Indonesia. Tjitra E; Hasugian AR; Siswantoro H; Prasetyorini B; Ekowatiningsih R; Yusnita EA; Purnamasari T; Driyah S; Salwati E; ; Yuwarni E; Januar L; Labora J; Wijayanto B; Amansyah F; Dedang TA; Purnama A; Malar J; 2012 Jun; 11():153. PubMed ID: 22554203 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and efficacy of piperaquine and chloroquine in Melanesian children with uncomplicated malaria. Karunajeewa HA; Ilett KF; Mueller I; Siba P; Law I; Page-Sharp M; Lin E; Lammey J; Batty KT; Davis TM Antimicrob Agents Chemother; 2008 Jan; 52(1):237-43. PubMed ID: 17967917 [TBL] [Abstract][Full Text] [Related]
18. Randomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria. Ndiaye JL; Randrianarivelojosia M; Sagara I; Brasseur P; Ndiaye I; Faye B; Randrianasolo L; Ratsimbasoa A; Forlemu D; Moor VA; Traore A; Dicko Y; Dara N; Lameyre V; Diallo M; Djimde A; Same-Ekobo A; Gaye O Malar J; 2009 Jun; 8():125. PubMed ID: 19505304 [TBL] [Abstract][Full Text] [Related]
19. Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study. Llanos-Cuentas A; Casapia M; Chuquiyauri R; Hinojosa JC; Kerr N; Rosario M; Toovey S; Arch RH; Phillips MA; Rozenberg FD; Bath J; Ng CL; Cowell AN; Winzeler EA; Fidock DA; Baker M; Möhrle JJ; Hooft van Huijsduijnen R; Gobeau N; Araeipour N; Andenmatten N; Rückle T; Duparc S Lancet Infect Dis; 2018 Aug; 18(8):874-883. PubMed ID: 29909069 [TBL] [Abstract][Full Text] [Related]
20. Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial. Ndiaye JL; Faye B; Gueye A; Tine R; Ndiaye D; Tchania C; Ndiaye I; Barry A; Cissé B; Lameyre V; Gaye O Malar J; 2011 Aug; 10():237. PubMed ID: 21838909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]